Story perspectives

Myriad Genetics to Reveal Q2 Earnings Amid Cautious Outlook

7/30/2025

22 4

Summary

Story summary

Myriad Genetics is set to unveil its Q2 2025 earnings on August 5 at 4:30 PM ET, accompanied by a conference call for financial insights. Investors can tune in via a live webcast or join by phone. Analysts remain divided, with a median stock price target of $8.5, hinting at a cautious outlook.

1 of 1

Story summary

Myriad Genetics is set to unveil its Q2 2025 earnings on August 5 at 4:30 PM ET, accompanied by a conference call for financial insights. Investors can tune in via a live webcast or join by phone. Analysts remain divided, with a median stock price target of $8.5, hinting at a cautious outlook.